Dr. Balser, President and CEO of VUMC and Dean of VUSM, said the emeritus distinction is bestowed on faculty who “have served the university with distinction and deep abiding commitment to their fields.”

Christopher Williams, MD, PhD (Gastroenterology, Hepatology and Nutrition), was recently awarded the 2025 Harvey Branscomb Distinguished Professor Award at the Vanderbilt University Spring Faculty Awards.

Evan Brittain, MD, MSCI (Cardiovascular Medicine), is corresponding author of a study recently published in JAMA Network Open that reported that U.S. veterans with depression had a 14% higher risk of heart failure, even after adjusting for traditional risk factors.

The grant will allow investigators to recruit additional participants and conduct methylation- and proteomics-based biological aging assays to check for biomarkers of early disease risk.

In a preclinical study conducted by Dr. Lauren Woodard (Nephrology and Hypertension) and colleagues, stem cells isolated from the urine of healthy donors stimulated regeneration of acutely injured kidney tissue.

The cellular therapy programs at Vanderbilt-Ingram Cancer Center, Monroe Carell Jr. Children’s Hospital at Vanderbilt, and the VA Tennessee Valley Healthcare System have received reaccreditation from the Foundation for the Accreditation of Cellular Therapy (FACT).